Skip to main content
Alphanox Co.,Ltd. logo

Alphanox Co.,Ltd. — Investor Relations & Filings

Ticker · 043100 ISIN · KR7043100007 KO Manufacturing
Open in API
Filings indexed 364 across all filing types
Latest filing 2024-03-22 Audit Report / Informat…
Country KR South Korea
Listing KO 043100

About Alphanox Co.,Ltd.

https://alphanox.co.kr/en/

Alphanox Co.,Ltd., formerly known as Solco Biomedical, is a global medical and healthcare group established in 1974. The company specializes in the development, manufacturing, and sale of advanced medical devices and health-promoting products. Its primary product lines include surgical instruments, orthopedic implants with a strong focus on spinal applications, and in-vitro diagnostic devices. In addition to its core medical offerings, Alphanox also produces healthcare products such as functional water and other health-promoting devices. The company is committed to improving quality of life through extensive research and development grounded in medical engineering and clinical results.

Recent filings

Filing Released Lang Actions
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Solco Biomedical Co., Ltd. for the fiscal year ending December 31, 2023. It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. While it contains financial data, it is specifically the audit report document required by regulatory standards, not a general annual report or a simple earnings release. Therefore, it falls under the 'Audit Report' category. FY 2023
2024-03-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of convertible bonds by MDS Intelligence Inc. in Solgo BioMedical, resulting in a significant ownership stake. This falls under the 'Major Shareholding Notification' category.
2024-03-21 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled 'Audit Report Submission' (감사보고서 제출) submitted to the Korea Exchange (KRX). It provides the audit opinion, key financial data (assets, liabilities, equity, profit/loss), and capital impairment ratios for the fiscal year. While it contains financial data, it is a standard regulatory disclosure form used to announce the completion and submission of the audit report to the regulator, rather than the full annual report document itself. Therefore, it falls under the category of a regulatory filing. FY 2023
2024-03-21 Korean
투자판단관련주요경영사항 (경영지배인 선임)
Board/Management Information Classification · 100% confidence The document is a regulatory filing from Solco Biomedical regarding the appointment of a new 'Management Manager' (경영지배인). This falls under the category of senior management changes, which is explicitly defined under the 'Board/Management Information' (MANG) category.
2024-03-19 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Solco Biomedical. It contains the meeting agenda, details on voting procedures (including electronic voting), and management's report on business activities and financial statements (including balance sheets and income statements) as required by Korean commercial law for shareholder meetings. This type of document is classified as Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on agenda items at the upcoming meeting.
2024-03-15 Korean
증권발행결과(자율공시) (제14회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Securities Issuance Result' (증권 발행결과) announcement regarding the issuance of convertible bonds (CB). It details the issuance method, amount, and payment date. This falls under the category of capital and financing updates, specifically related to the company's capital structure changes through debt financing.
2024-03-15 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.